These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22517097)

  • 1. Identification of VPS35 mutations replicated in French families with Parkinson disease.
    Lesage S; Condroyer C; Klebe S; Honoré A; Tison F; Brefel-Courbon C; Dürr A; Brice A;
    Neurology; 2012 May; 78(18):1449-50. PubMed ID: 22517097
    [No Abstract]   [Full Text] [Related]  

  • 2. The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.
    Guella I; Soldà G; Cilia R; Pezzoli G; Asselta R; Duga S; Goldwurm S
    Mov Disord; 2012 May; 27(6):800-1. PubMed ID: 22278960
    [No Abstract]   [Full Text] [Related]  

  • 3. Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.
    Zhang Y; Chen S; Xiao Q; Cao L; Liu J; Rong TY; Ma JF; Wang G; Wang Y; Chen SD
    Parkinsonism Relat Disord; 2012 Jun; 18(5):638-40. PubMed ID: 22410496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.
    Verstraeten A; Wauters E; Crosiers D; Meeus B; Corsmit E; Elinck E; Mattheijssens M; Peeters K; Cras P; Pickut B; Vandenberghe R; Engelborghs S; De Deyn PP; Van Broeckhoven C; Theuns J
    Neurobiol Aging; 2012 Aug; 33(8):1844.e11-3. PubMed ID: 22336192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation on a theme: identifying sequence variation in disease genes and defining pathogenicity.
    Clark LN
    Neurology; 2009 Jun; 72(22):1882-3. PubMed ID: 19386995
    [No Abstract]   [Full Text] [Related]  

  • 6. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
    Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in VPS26A are not a frequent cause of Parkinson's disease.
    Koschmidder E; Mollenhauer B; Kasten M; Klein C; Lohmann K
    Neurobiol Aging; 2014 Jun; 35(6):1512.e1-2. PubMed ID: 24417787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
    Chen Y; Chen K; Song W; Chen X; Cao B; Huang R; Zhao B; Guo X; Burgunder J; Li J; Shang HF
    Neurobiol Aging; 2013 Jun; 34(6):1709.e7-8. PubMed ID: 23261770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of the D620N mutation in VPS35 in Parkinson disease.
    Kumar KR; Weissbach A; Heldmann M; Kasten M; Tunc S; Sue CM; Svetel M; Kostić VS; Segura-Aguilar J; Ramirez A; Simon DK; Vieregge P; Münte TF; Hagenah J; Klein C; Lohmann K
    Arch Neurol; 2012 Oct; 69(10):1360-4. PubMed ID: 22801713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taiwanese cases of SCA2 are derived from a single founder.
    Momeni P; Lu CS; Chou YH; Chang HC; Chen RS; Chen CC; Hsu JT; Singleton A; Hardy J
    Mov Disord; 2005 Dec; 20(12):1633-6. PubMed ID: 16078202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease.
    Choi JM; Hong JH; Chae MJ; Ngyuen PH; Kang HS; Ma HI; Kim YJ
    Neurosci Lett; 2011 Apr; 493(3):97-101. PubMed ID: 21320571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
    Zimprich A; Benet-Pagès A; Struhal W; Graf E; Eck SH; Offman MN; Haubenberger D; Spielberger S; Schulte EC; Lichtner P; Rossle SC; Klopp N; Wolf E; Seppi K; Pirker W; Presslauer S; Mollenhauer B; Katzenschlager R; Foki T; Hotzy C; Reinthaler E; Harutyunyan A; Kralovics R; Peters A; Zimprich F; Brücke T; Poewe W; Auff E; Trenkwalder C; Rost B; Ransmayr G; Winkelmann J; Meitinger T; Strom TM
    Am J Hum Genet; 2011 Jul; 89(1):168-75. PubMed ID: 21763483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.
    Kumazawa R; Tomiyama H; Li Y; Imamichi Y; Funayama M; Yoshino H; Yokochi F; Fukusako T; Takehisa Y; Kashihara K; Kondo T; Elibol B; Bostantjopoulou S; Toda T; Takahashi H; Yoshii F; Mizuno Y; Hattori N
    Arch Neurol; 2008 Jun; 65(6):802-8. PubMed ID: 18541801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the APP gene promoter region and risk of Alzheimer disease.
    Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
    Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.
    Guo JF; Sun QY; Lv ZY; Yu RL; Li K; Zhang YH; Tian JY; Xia K; Yan XX; Tang BS
    Parkinsonism Relat Disord; 2012 Sep; 18(8):983-5. PubMed ID: 22673036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients.
    Zadikoff C; Rogaeva E; Djarmati A; Sato C; Salehi-Rad S; St George-Hyslop P; Klein C; Lang AE
    Mov Disord; 2006 Jun; 21(6):875-9. PubMed ID: 16547921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
    Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin genetic variability contributes to amyotrophic lateral sclerosis.
    Sleegers K; Brouwers N; Maurer-Stroh S; van Es MA; Van Damme P; van Vught PW; van der Zee J; Serneels S; De Pooter T; Van den Broeck M; Cruts M; Schymkowitz J; De Jonghe P; Rousseau F; van den Berg LH; Robberecht W; Van Broeckhoven C
    Neurology; 2008 Jul; 71(4):253-9. PubMed ID: 18184915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.